The Leadership Team at Wugen is responsible for guiding the strategic direction and operational execution of the company’s clinical-stage immuno-oncology initiatives. This team, comprised of executives with expertise in research and development, clinical operations, and strategy, collaborates to drive innovation in developing off-the-shelf NK and CAR-T cell therapies, ensuring alignment with Wugen's mission to advance treatment options for solid tumors and hematologic malignancies.